Mu Lai An - Net Worth and Insider Trading
Mu Lai An Net Worth
The estimated net worth of Mu Lai An is at least $0 dollars as of 2025-04-10. Mu Lai An is the Director of Shanghai Kaibao Pharmaceutical Co Ltd and owns about 0 shares of Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) stock worth over $0. Details can be seen in Mu Lai An's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mu Lai An has not made any transactions after 2015-07-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Mu Lai An
Mu Lai An Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mu Lai An owns 1 companies in total, including Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) .
Click here to see the complete history of Mu Lai An’s form 4 insider trades.
Insider Ownership Summary of Mu Lai An
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SZSE:300039 | Shanghai Kaibao Pharmaceutical Co Ltd | 2015-07-17 | Director |
Mu Lai An Latest Holdings Summary
Mu Lai An currently owns a total of 1 stock. Mu Lai An owns 0 shares of Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) as of July 17, 2015, with a value of $0.
Latest Holdings of Mu Lai An
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SZSE:300039 | Shanghai Kaibao Pharmaceutical Co Ltd | 2015-07-17 | 0 | 6.10 | 0 |
Holding Weightings of Mu Lai An
Mu Lai An Form 4 Trading Tracker
According to the SEC Form 4 filings, Mu Lai An has made a total of 0 transactions in Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) over the past 5 years. The most-recent trade in Shanghai Kaibao Pharmaceutical Co Ltd is the acquisition of 42,600 shares on July 17, 2015, which cost Mu Lai An around $788,100.
Insider Trading History of Mu Lai An
- 1
Mu Lai An Trading Performance
GuruFocus tracks the stock performance after each of Mu Lai An's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mu Lai An is -27.56%. GuruFocus also compares Mu Lai An's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mu Lai An within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mu Lai An's insider trading performs compared to the benchmark.
Mu Lai An Ownership Network
Ownership Network List of Mu Lai An
Ownership Network Relation of Mu Lai An

Mu Lai An Owned Company Details
What does Shanghai Kaibao Pharmaceutical Co Ltd do?
Who are the key executives at Shanghai Kaibao Pharmaceutical Co Ltd?
Mu Lai An is the Director of Shanghai Kaibao Pharmaceutical Co Ltd. Other key executives at Shanghai Kaibao Pharmaceutical Co Ltd include Secretary Dong Ren Li Wang , Supervisors Liu Shao Yong , and Executives Zhang Tao .
Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shanghai Kaibao Pharmaceutical Co Ltd Insider Transactions
Mu Lai An Mailing Address
Above is the net worth, insider trading, and ownership report for Mu Lai An. Currently GuruFocus does not have mailing address information for Mu Lai An.